GIUSTI, MASSIMO
 Distribuzione geografica
Continente #
EU - Europa 11.346
Totale 11.346
Nazione #
IT - Italia 11.346
Totale 11.346
Città #
Genova 9.149
Rapallo 1.327
Genoa 844
Bordighera 26
Totale 11.346
Nome #
1,25-Dihydroxy vitamin D and coronary microvascular function 282
Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre. 167
Characteristics of a nationwide cohort of patients presenting with Isolated Hypogonadotropic Hypogonadism (IHH) 145
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system 141
Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease 136
The pathology of the ulnar nerve in acromegaly. 134
A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma 132
Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy 130
The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis. 128
Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR 127
A case of thyroid cancer on the track of the radiofrequency electrode 30 months after percutaneous ablation 126
Absence of histological malignancy in a patient cohort with follicular lesions on fine-needle aspiration 125
Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone 125
Increasing hirsutism due to a granulosa-cell tumor in a woman with polycystic ovary syndrome: case report and review of the literature. 125
Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. 123
A study of the efficacy of radioiodine therapy with individualized dosimetry in Graves' disease: need to retarget the radiation committed dose to the thyroid. 123
Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells 123
Clinical efficacy of radioiodine therapy in multinodular toxic goiter, applying an implemented dose calculation algorithm. 122
Nitric oxide modulates in vivo and in vitro growth hormone release in acromegaly. 121
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study. 121
Evaluation of adequacy of levo-thyroxine dosage in patients with differentiated thyroid carcinoma: correlation between morning and afternoon TSH determination 121
Circulating nitric oxide in women affected by weight loss amenorrhea during pulsatile gonadotropin-releasing hormone therapy 120
Growth-hormone, prolactin and cortisol nyctohemeral variations during naloxone-induced opiate receptor blockade in man. 119
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 117
Detection of Polyethylene Glycol Thyrotropin (TSH) Precipitable Percentage (Macro-TSH) in Patients with a History of Thyroid Cancer 117
Quality of Life in Patients Treated with Percutaneous Laser Ablation for Non-Functioning Benign Thyroid Nodules: A Prospective Single-Center Study 117
Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature review. 116
Morphine-induced TSH release in normal and hypothyroid subjects. 115
Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose. 115
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. 115
Sympathovagal imbalance in acromegalic patients 114
Severe vitamin D deficiency is associated with frequently observed diseases in medical inpatients 113
An H-TERT Mutated Skin Metastasis as First Occurrence in a Case of Follicular Thyroid Carcinoma 113
Parathyroid autotransplantation. 112
Androgen replacement therapy in male patients with rheumatoid arthritis. 111
Increased prevalence of Helicobacter pylori infection in females treated with dopaminergic drugs for hyperprolactinaemia. 110
Slow-release lanreotide and octreotide LAR in the medical therapy of acromegaly. 109
Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer 109
Low-Salt Intake Suggestions in Hypertensive Patients Do not Jeopardize Urinary Iodine Excretion 108
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter. 107
Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications 107
In memory of Francesco Maria Minuto. 107
Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. 106
Institutional experience of PTH evaluation on fine-needle washing after aspiration biopsy to locate hyperfunctioning parathyroid tissue. 106
Simple dietary advice reduces 24-hour urinary sodium excretion, blood pressure, and drug consumption in hypertensive patients 106
Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments 105
Case report: lenvatinib in neoadjuvant setting in a patient affected by invasive poorly differentiated thyroid carcinoma 105
Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy. 104
Primary hyperparathyroidism in pregnancy treated with cinacalcet: A case report and review of the literature 104
Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients 104
Prolactin decrease and shift to a normal-like isoform profile during treatment with quinagolide in a patient affected by an invasive prolactinoma. 103
A comparison of laser with radiofrequency ablation for the treatment of benign thyroid nodules: a propensity score matching analysis 103
Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center 102
Can baseline endocrinological examination and thyroid ultrasound predict the development of thyroid disease in immunotherapy-treated patients? Results from a prospective, single-center, open-label study 102
A unique association of clinical "persistent müllerian duct syndrome" and syringoid carcinoma of the perineal-scrotal skin: a consequence of urologic surgery? 102
Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing 101
Benign thyroid nodule unresponsive to radiofrequency ablation treated with laser ablation: a case report 99
Role of Strain Elastography and Shear-Wave Elastography in a Multiparametric Clinical Approach to Indeterminate Cytology Thyroid Nodules 99
Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study 98
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 98
Is there a real diagnostic impact of elastosonography and contrast-enhanced ultrasonography in the management of thyroid nodules? 97
A case of thyroiditis during natalizumab therapy for multiple sclerosis 97
Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis. 96
Evaluation of Quality of Life in Patients with Differentiated Thyroid Cancer by Means of the Thyroid-Specific Patient-Reported Outcome Questionnaire: A 5-Year Longitudinal Study 96
Ranitidine and testosterone secretion in man. 95
Retrospective cytological evaluation of indeterminate thyroid nodules according to the British Thyroid Association 2014 classification and comparison of clinical evaluation and outcomes 94
Replacement therapy and cardiovascular diseases 93
Desmopressin and low-dose ACTH test in rheumatoid arthritis. 92
Cost-of-illness study in acromegalic patients in Italy 92
Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database 92
Papillary thyroid cancer in a struma ovarii: a report of a rare case 92
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogs and dopastatins 91
Desmopressin, ovine CRH, and low-dose ACTH tests: tools for the study of the hypothalamic-pituitary-adrenal axis in premenopausal rheumatoid arthritis patients. 91
Androgen status in postmenopausal patients with rheumatoid arthritis. 91
Testosterone metabolism and cyclosporin A treatment in rheumatoid arthritis. 91
Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly. 88
Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6. 88
Current diagnostic guidelines for biochemical diagnosis of acromegaly. 85
A. novel mechanism for the melatonin inhibition of testosterone secretion by rat Leydig cells: reduction of GnRH-induced cytosolic Ca2+ rise 84
Cabergoline modulation of alpha-subunits and FSH secretion in a gonadotroph adenoma 84
Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly. 83
Preliminary results of serum androgen level testing in men with rheumatoid arthritis. 83
Desmopressin, ovineCRH and low-dose ACTH tests: tools for the study of hypotalamus- pituitary-adrenal axis in premenopausal rheumatoid arthritis patients 82
Syndrome of inappropriate antidiuretic hormone secretion and Ibuprofen, a rare association to be considered: role of tolvaptan. 81
Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. 81
Five-year longitudinal evaluation of quality of life in a chort of patients with different thyroid carcinoma 81
Effects of melatonin on interleukin – 12 and nitric oxide production by cultured synovial macrophages in rheumatoid arthritis 80
In vitro effect of human recombinant leptin and expression of leptin receptors on growth hormone-secreting human pituitary adenomas 79
CYP17 polymorphisms and androgen levels in postmenopausal patients with rheumatoid arthritis. 77
Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders 77
Altered stress response of adrenal steroids in premenopausal rheumatoid arthritis patients 77
Effects of recombinant human thyrotropin on heart rate variability and blood pressure in patients on l-thyroxine-suppressive therapy for differentiated thyroid carcinoma 76
Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency. 75
PTH radioimmunoassay and loading tests in the diagnosis of patients with primary hyperparathyroidism. 73
The hypothalamic-pituitary-adrenal and gonadal axes in rheumatoid arthritis. 71
Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro 70
Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study Group. 70
A very low vitamin D threshold, within the range of severe deficiency, identifies an increased risk of non-classical vitamin D-related outcomes in medical inpatients: a role for parathyroid hormone? 68
Sympatho-vagal control of heart rate variability in patients treated with suppressive doses of l-thyroxine for thyroid cancer 66
Papillary carcinoma in struma ovarii: A case report 65
Totale 10.439
Categoria #
all - tutte 28.180
article - articoli 27.615
book - libri 0
conference - conferenze 565
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.360


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019719 0 0 0 0 0 0 0 0 0 145 320 254
2019/20203.584 152 78 168 233 336 419 546 235 362 555 364 136
2020/20211.050 58 96 127 63 67 101 75 113 93 100 74 83
2021/20221.447 53 78 113 183 72 108 81 296 105 142 61 155
2022/20231.563 143 113 24 156 335 250 11 108 233 6 168 16
2023/2024640 41 95 6 108 75 146 54 36 43 36 0 0
Totale 11.497